跳至主要内容
临床试验/CTRI/2018/01/011122
CTRI/2018/01/011122尚未招募2 期

Accuracy of core biopsy in predicting pathological complete response in the breast in patients with complete clinical and radiological response post chemotherapy (CRBr) - A feasibility study

Basavatarakam Indo American Cancer Hospital Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients willing to provide informed consent
  • 2. Patients with newly diagnosed non metastatic breast cancer who have no clinically or radiologically demonstrable disease following neoadjuvant chemotherapy as seen on a mammogram and ultrasound of the breast.

排除标准

  • 1. Patients with prior history of any malignancy
  • 2. Patients with excision biopsy of the breast primary
  • 3. Patients undergoing upfront surgery
  • 4. Pregnant or lactating women

研究者

发起方
Basavatarakam Indo American Cancer Hospital Research Institute

相似试验